• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence - The Lancet

Mary Wilson

Well-known member
Published:January 27, 2021
DOI:https://doi.org/10.1016/S0140-6736(21)00183-5

Ester C Sabino, Lewis F Buss, Maria P S Carvalho, Carlos A Prete Jr, Myuki A E Crispim, Nelson A Fraiji, Rafael H M Pereira, Kris V Parag, Pedro da Silva Peixoto, Moritz U G Kraemer, Marcio K Oikawa, Tassila Salomon, Zulma M Cucunuba, M?rcia C Castro, Andreza Aruska de Souza Santos, V?tor H Nascimento, Henrique S Pereira, Neil M Ferguson, Oliver G Pybus, Adam Kucharski, Michael P Busch, Christopher Dye, Nuno R Faria


After initially containing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many European and Asian countries had a resurgence of COVID-19 consistent with a large proportion of the population remaining susceptible to the virus after the first epidemic wave.
[SUP]1[/SUP] By contrast, in Manaus, Brazil, a study of blood donors indicated that 76% (95% CI 67–98) of the population had been infected with SARS-CoV-2 by October, 2020.
[SUP]2[/SUP] High attack rates of SARS-CoV-2 were also estimated in population-based samples from other locations in the Amazon Basin—eg, Iquitos, Peru 70% (67–73).
[SUP]3[/SUP] The estimated SARS-CoV-2 attack rate in Manaus would be above the theoretical herd immunity threshold (67%), given a basic case reproduction number (R[SUB]0[/SUB]) of 3.
[SUP]4[/SUP]In this context, the abrupt increase in the number of COVID-19 hospital admissions in Manaus during January, 2021 (3431 in Jan 1–19, 2021, vs 552 in Dec 1–19, 2020) is unexpected and of concern (figure).[SUP]5[/SUP][SUP], [/SUP][SUP]6[/SUP][SUP], [/SUP][SUP]7[/SUP][SUP], [/SUP][SUP]8[/SUP][SUP], [/SUP][SUP]9[/SUP][SUP], [/SUP][SUP]10[/SUP]

After a large epidemic that peaked in late April, 2020, COVID-19 hospitalisations in Manaus remained stable and fairly low for 7 months from May to November, despite the relaxation of COVID-19 control measures during that period (figure). ...

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00183-5/fulltext
 
Back
Top Bottom